Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: Implications for needle length recommendations

Current Medical Research and Opinion

Volumn 26, Issue 6, 2010, Pages 1519-1530

  Gibney, Michael A ^a   Arce, Christina H ^a   Byron, Karen J ^a   Hirsch, Laurence J ^a  

^a BD Technologies   (United States)

Author keywords

Diabetes; Needle; Skin thickness; Subcutaneous thickness; Ultrasound

Indexed keywords

INSULIN;

ABDOMEN; ADULT; AGED; ARM; ARTICLE; BODY MASS; BUTTOCK; CONTROLLED STUDY; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; GLYCEMIC CONTROL; HUMAN; INJECTION SITE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEEDLE; RACE DIFFERENCE; SEX DIFFERENCE; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; THIGH; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRADERMAL; INSULIN; MALE; MIDDLE AGED; NEEDLES; SKIN; SUBCUTANEOUS FAT; UNITED STATES; YOUNG ADULT;

EID: 77952502681     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.481203     Document Type: Article

References (34)

1. Kolendorf K, Bojsen J, Deekert T. Clinical factors influencing the absorption of 125 I-NPH insulin in diabetic patients. Horm Metab Res 1983;15:274-278
2. Thow JC, Johnson AB, Fulcher G, et al. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique. Diabet Med 1990;7:600-602
3. Thow JC, Home PD. Insulin injection technique: depth of injection is important. Br Med J 1990;301:3-4
4. Engstrom L. Technique of insulin injection: is it important? Pract Diab 1994;11:39
5. Strauss K, De Gols H, Letondeur C, et al. The Second Injection Technique Event (SITE), May 2000, Barcelona Spain). Pract Diab Int 2002;19:17-21
6. Matsumura M, Monden Y, Nakatani T, et al. Improvement of glycemic control by reeducation in insulin injection technique. Diabetes 2007;56(S1): Abstract 0157-OR
7. Vaag A, Pedersen KD, Lauritzen M, et al. Intramuscular verse subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Diab Med 1990;7:335-342
8. Owens DR, Coates PA, Luzio SD, et al. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care 2000;23:813-819
9. Clauson PG, Linde B. Absorption of rapid-acting insulin in obese and non-obese NIDDM patients. Diabetes Care 1995;18:986-991
10. Hildebrandt P, Sestoft L, Nielsen SL. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration. Diabetes Care 1983;6:459-462
11. Heinemann L. Variability of insulin absorption and insulin action. Diab Technol Ther 2002;4:673-682
12. Frid A, Gunnarsson R, Gü ntner P, et al. Effects of accidental intramuscular injection on insulin absorption in IDDM. Diabetes Care 1988;11:41-45
13. Polak M, Beregszaszi M, Belarbi Ni, et al. Subcutaneous or intramuscular injections of insulin in children. Are we injecting where we think we are? Diabetes Care 1996;19:1434-1436
14. Frid A, Lindén B. Where do lean diabetics inject their insulin? A study using computed tomography. Br Med J (Clin Res Ed) 1986;292:1638
15. Vaag A, Handberg A, Lauritzen M, et al. Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care 1990;13:74-76
16. Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L, et al. Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care 1999;22:1621-1625
17. Laurent A, Mistretta F, Bottigioli D, et al. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 2007; 25:6423-6430
18. Schwartz S, Hassman D, Shelmet J, etal. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 Gauge × 6 mm needle versus a 29 Gauge × 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther 2004; 26:1663-1678
19. Hofman PL, Lawton SA, Peart JM, et al. An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents. Diabet Med 2007;24:1400-1405
20. Birkebaek NH, Solvig J, Hansen B, et al. A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care 2008;31:e65; doi:10.2337/dc08-0977
21. Nordander C, Willner J, Hansson G. Skerfving influence of the subcutaneous fat layer, as measured by ultrasound, skinfold calipers and BMI, on the EMG amplitude. Eur J Appl Physiol 2003;89:514-519
22. Poland GA, Borrud A, Jacobson RM, et al. Determination of deltoid fat pad thickness, implications for needle length in adult immunization. JAMA 1997;277:1709-1711
23. Cash CJC, Berman LH, Treece GM, et al. Two-and three-dimensional ultrasound in the development of a needle-free injection system. Br J Radiol 2004;77:236-242
24. Schou AJ, Thomsen K, Plomgaard AM, et al. Methodological aspects of high-frequency ultrasound of skin in children. Skin Res Technol 2004;10:200-206
25. Gniadecka M. Effects of ageing on dermal echogenicity. Skin Res Technol 2001;7:204-207
26. Smith L. Histologic characteristics and ultrastructure of ageing skin. Cutis 1989;43:414-424
27. Gniedecka M, Jemec GBE. Quantitative evaluation of chronological ageing and photo ageing in vivo: studies on skin echogenicity and thickness. Br J Derm 1998;139:815-821
28. SeidenariS, GiustiG, Bertoni L, etal. Thickness and echogenicity of the skin in children as assessed by 20-MHz ultrasound. Dermatology 2000;201:218-222
29. Burbridge BE. Computed tomographic measurement of gluteal subcutaneous fat thickness in reference to failure of gluteal intramuscular injections. Can Assoc Radiol J 2007;58:72-75
30. Birkebaek NH, Johansen A, Slovig J. Cutis/subcutis thickness at insulin injection sites and localization of simulated insulin boluses in children with type 1 diabetes mellitus: need for individualization of injection technique? Diabet Med 1998;15:965-971
31. Frid A, Linde B. Intraregional differences in the absorption of unmodified insulin from the abdominal wall. Diabet Med 1992;9:236-239
32. Hirsch LJ, Klaff LJ, Bailey TS, et al. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin 2010;26:1531-1541
33. Kreugel G, Keers JC, Jongbloed A, et al. The influence of needle length on glycemic control and patient preference in obese diabetic patients. Diabetes 2009;58(S1): Abstract 440-P
34. Strauss K, Hannet I, McGonigle J, et al. Ultra-short (5 mm) insulin needles: trial results and clinical recommendations. Pract Diab Int 1999;16:218-222